Condition: AMD - Age-Related Macular Degeneration · Sponsor: Marco Mazzola
This study investigates the prognostic value of macular neovascularization (MNV) subtypes in patients treated with pneumatic displacement for submacular hemorrhage. The researchers will compare anatomical and functional outcomes (visual acuity) between PCV, RAP, and other MNV forms within a Caucasian cohort to identify subtype-specific predictors of recovery.
This description comes directly from the study's public registry record.
marco mazzola, medical doctor · +393479950266 · marco.mazzola@asuit.tn.it
tommaso brighenti, MD · +393484780821 · tommaso.brighenti@asuit.tn.it
Always discuss trial participation with your own doctor first.
| Ospedale Santa Chiara Di Trento | Trento, Trento, Italy | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07427160